protein

Semenogelin-1 Protein, Human (HEK293, His)

HY-P71287

10 μg;50 μg

115;320 USD

Semenogelin-1 Protein, Human (HEK293, His)

proteins

HEK293

10 μg;50 μg

115;320 USD

Semenogelin-1 Protein is a major protein in semen and is involved in the formation of a gel matrix that encapsulates accessory glandular secretions and ejaculated sperm. Semenogelin-1 Protein can be hydrolyzed by prostate-specific antigen (PSA) protease to produce a variety of peptide products with different functions. Semenogelin-1 Protein is a predictor of cancer progression and prognosis. Semenogelin-1 Protein, Human (HEK293, His) is the recombinant human-derived Semenogelin-1 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Semenogelin-1 Protein, Human (HEK293, His) is 379 a.a., with molecular weight of 29-54 kDa.

Human

Semenogelin-1 is the main protein in semen and is involved in the formation of a gel matrix that encapsulates accessory glandular secretions and ejaculated sperm. Semenogelin-1 can be hydrolyzed by prostate-specific antigen (PSA) protease to produce a variety of peptide products with different functions. One of these peptides, SgI-29, is an antimicrobial peptide with antimicrobial activity. The Semenogelin-1 hydrolysis process also breaks down the gel matrix, allowing the sperm to move more freely. Semenogelin-1 can be used as a predictor of cancer progression and prognosis [1] [2] [3] [4] .

Semenogelin-1; Semenogelin I; SGI; SEMG1; SEMG; Alpha-Inhibin-92; Alpha-Inhibin-31; Seminal Basic Protein

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized from a 0.2 μm filtered solution of 20 mM HAc-NaAc, 150 mM NaCl, pH 4.5.

Room temperature in continental US; may vary elsewhere.